News and Insights of 3D Printing and Manufacturing
Researchers at RWTH Aachen University’s Chair Digital Additive Production (DAP), working with the reACT alliance, are developing bioresorbable implants designed to fit each patient’s needs.
Stratasys Ltd. (NASDAQ: SSYS), a manufacturer of polymer 3D printing solutions, and Siemens Healthineers, a global provider of medical imaging technology, have introduced patient-specific 3D printed phantoms designed to enhance computed tomography (CT) imaging. Research presented at the Radiological Society of North America (RSNA) annual meeting demonstrates the accuracy of these models, which replicate human anatomy with high precision.
Researchers at Pusan National University (PNU) have developed a way to 3D print fat tissue that could speed up wound healing, offering potential relief for patients with chronic injuries and burns.
Lincotek’s Medical Division has secured a patent for a 3D printed screw designed to enhance bone ingrowth and offer greater customization for orthopedic procedures.
CAD-Ray, a provider of digital dentistry solutions with over 100 years of experience in dental scanning and milling, and Zylo3D, a company founded in 2023 specializing in automated, all-in-one chairside 3D printing, have partnered to offer a comprehensive dental 3D printing solution. This new solution integrates Zylo3D’s AI-driven software with CAD-Ray’s focus on affordability.
Chinese drug 3D printing firm Triastek has announced that its 3D printed drug product, D23, Budesonide Ileum Targeted Tablets for the treatment of IgAN (Immunoglobulin A Nephropathy)—a kidney disorder characterized by the buildup of immunoglobulin A (IgA) deposits in the kidneys—has demonstrated favorable results in a recent clinical study.
MB Therapeutics, a Montpellier-based startup with over 8 years of expertise in pharmaceutical 3D printing, has secured €2 million in seed funding to develop the first pharmaceutical facility designed to provide 3D printing compatible solutions for pharmacies. This facility will help pharmacies produce personalized medicines on-site, improving precision and meeting the growing demand for individualized treatments. The funding will also enable the launch of three high-demand medicines and prepare the company for a Series A funding round in 2026.
In the battle against herpes simplex virus (HSV), 3D printing technology is offering a new approach to drug development by creating models of human skin. Current antiviral drugs often fall short because they cannot replicate the complexity of human tissue. To address this, Dr. Jia Zhu from the Fred Hutch Vaccine and Infectious Disease Division, alongside biofabrication experts Dr. Ian Hayman and Dr. Tori Ellison, is using 3D printing to develop these models, enhancing the precision of virus studies.
US-based 3D printer manufacturer 3D Systems has introduced its latest developments in dental 3D printing at LMT Lab Day 2025 at the Hyatt Regency Chicago.
Katie Weimer, former Vice President of Regenerative Medicine 3D Systems’ has launched GenesisTissue Inc., a biotechnology research startup.